KTTA Analyst Ratings 2026
Pasithea Therapeutics Corp - Wall Street recommendations & price targets
Consensus Rating
N/A
Current Price
$0.74
Get Complete KTTA Analysis
AI insights, DCF valuation, and institutional ownership
View Full AnalysisFrequently Asked Questions
What is the analyst rating for KTTA?
Analyst rating data for KTTA is being updated. Check back for the latest Wall Street recommendations.
What is the KTTA price target?
Price target data for KTTA is being updated.
Is KTTA a buy according to analysts?
Check the latest analyst recommendations for KTTA.
How many analysts cover KTTA?
Analyst coverage information for KTTA is being updated.